Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced the latest extension of their first-of-its kind, multi-year campaign, ‘Beauty on Your Terms’ with the addition of award-winning actor and musician Demi Lovato as the newest Xeomin (incobotulinumtoxinA) brand partner.

The partnership with Lovato is a continuation of Merz Aesthetics’ multi-channel, digital-first ‘Beauty on Your Terms’ campaign, which has reimagined traditional pharmaceutical marketing strategy. First launched in August 2022, the campaign was developed to introduce Xeomin, an FDA-approved double-filtered anti-wrinkle injection to temporarily improve the appearance of frown lines, to a younger adult audience that is new to the injectables category and to empower them to embrace beauty on their own terms.

Read more at Business Wire >>